Malignant neoplasm of cervix uteri
Chapter 2:Neoplasms
ICD-10 C53 is a billable code used to indicate a diagnosis of malignant neoplasm of cervix uteri.
C53 refers to malignant neoplasms of the cervix uteri, which are cancers that arise from the cervical tissue. The cervix is the lower part of the uterus that connects to the vagina. The most common type of cervical cancer is squamous cell carcinoma, followed by adenocarcinoma. Risk factors include persistent infection with high-risk human papillomavirus (HPV), smoking, and immunosuppression. Symptoms may include abnormal vaginal bleeding, pelvic pain, and unusual discharge. Diagnosis typically involves a Pap smear, HPV testing, and biopsy. Staging of cervical cancer is crucial for determining treatment options and prognosis, classified from Stage 0 (carcinoma in situ) to Stage IV (advanced disease). CA-125 is a tumor marker that may be elevated in some cases, but it is not specific for cervical cancer. Treatment options include surgery (such as hysterectomy), radiation therapy, and chemotherapy, depending on the stage and overall health of the patient.
Detailed pathology reports, staging information, treatment plans, and follow-up care notes.
Diagnosis and management of cervical cancer, including pre-operative assessments and post-operative care.
Ensure accurate coding of the specific type of cervical cancer and any associated procedures.
Radiation treatment plans, dosimetry calculations, and patient response assessments.
Administration of radiation therapy for cervical cancer treatment.
Documentation must clearly link the diagnosis to the treatment provided.
Performed for treatment of cervical cancer.
Operative report detailing the procedure and findings.
Gynecologic oncology specialists must ensure accurate coding of the procedure.
Used to confirm diagnosis of cervical cancer.
Pathology report must be linked to the diagnosis.
Ensure that the pathology report is complete and accurate.
Common symptoms include abnormal vaginal bleeding, pelvic pain, and unusual discharge. Early-stage cervical cancer may not present any symptoms.
Cervical cancer is staged using the FIGO system, which classifies the cancer from Stage 0 (carcinoma in situ) to Stage IV (advanced disease).
